{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:18:40Z","timestamp":1782778720279,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NB01OT009090-01"],"award-info":[{"award-number":["NB01OT009090-01"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["TI010055-17"],"award-info":[{"award-number":["TI010055-17"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103644"],"award-info":[{"award-number":["P20GM103644"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ypmed.2019.105785","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T01:40:06Z","timestamp":1564191606000},"page":"105785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system"],"prefix":"10.1016","volume":"128","author":[{"given":"Richard A.","family":"Rawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci","family":"Rieckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2019.105785_bb0005","author":"Blau"},{"issue":"4","key":"10.1016\/j.ypmed.2019.105785_bb0010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact","volume":"11","author":"Brooklyn","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ypmed.2019.105785_bb0015","author":"Centers for Disease Control and Prevention, National Center for Health Statistics"},{"key":"10.1016\/j.ypmed.2019.105785_bb0020","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","article-title":"Patient adherence and medical treatment outcomes a meta-analysis","author":"Dimatteo","year":"2002","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.ypmed.2019.105785_bb0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08897077.2015.1088496","article-title":"Optimizing psychosocial support during office-based buprenorphine treatment in primary care: patients' experiences and preferences","volume":"37","author":"Fox","year":"2016","journal-title":"Subst. Abus."},{"issue":"1","key":"10.1016\/j.ypmed.2019.105785_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13011-016-0085-y","article-title":"Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study","volume":"12","author":"Hewell","year":"2017","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"issue":"4","key":"10.1016\/j.ypmed.2019.105785_bb0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/ADM.0b013e3181cc9610","article-title":"Patients' reasons for choosing office-based buprenorphine: preference for patient-centered care","volume":"4","author":"Korthuis","year":"2010","journal-title":"J. Addict. Med."},{"issue":"4","key":"10.1016\/j.ypmed.2019.105785_bb0040","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s10461-010-9779-8","article-title":"Substance use and the quality of patient-provider communication in HIV clinics","volume":"15","author":"Korthuis","year":"2011","journal-title":"AIDS Behav."},{"issue":"13","key":"10.1016\/j.ypmed.2019.105785_bb0045","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2019.105785_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2016.05.002","article-title":"Impact of medication-assisted treatment for opioid addiction on Medicaid expenditures and health services utilization rates in Vermont","volume":"67","author":"Mohlman","year":"2016","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.ypmed.2019.105785_bb0055","series-title":"The Content Analysis Guidebook","author":"Neuendorf","year":"2002"},{"issue":"34","key":"10.1016\/j.ypmed.2019.105785_bb0060","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","article-title":"Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region\u2014United States, 2006\u20132015","volume":"66","author":"O'Donnell","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2019.105785_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsat.2018.11.003","article-title":"Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system","volume":"97","author":"Rawson","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.ypmed.2019.105785_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ypmed.2015.04.002","article-title":"Vermont responds to its opioid crisis","volume":"80","author":"Simpatico","year":"2015","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2019.105785_bb0075","series-title":"Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health","author":"U.S. Department of Health and Human Services (HHS), Office of the Surgeon General","year":"2016"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743519302610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743519302610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T17:12:05Z","timestamp":1574442725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743519302610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":15,"alternative-id":["S0091743519302610"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2019.105785","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2019.105785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105785"}}